Annalisa Jenkins MBBS
Senior biotech executive, former Head of R&D at Merck Serono, and former Head of Global Medical Affairs at Bristol-Myers Squibb
Annalisa was previously Head of R&D at Merck Serono and Global Medical Senior Vice-President at Bristol-Myers Squibb. She recently served as CEO of PlaqueTec, a biotechnology company focusing on coronary artery disease treatment and prevention. She chairs and serves on the boards of a number of private and public companies in the life sciences industry, in the US and UK.